Sep 2026· Journal of Alzheimer's Disease· Vol 114, pp. 267 - 275· 0 citations· 36 references
Medicine
TL;DR
Non-motor symptom profiles differ among these dementia subtypes even at early stages, suggesting their potential utility as early disease-specific indicators.
Abstract
Background Current knowledge regarding the nature and prevalence of non-motor symptoms across different types of dementia is limited. While Alzheimer's disease (AD), behavioral variant frontotemporal dementia (bvFTD), and dementia with Lewy bodies (DLB) are primarily characterized by cognitive and motor symptoms, several other features such as non-motor symptoms are also known to occur in all these conditions. Objective To assess non-motor symptoms in early-stage dementia and characterize symptom profiles across different neurodegenerative dementia diseases. Methods A total of 64 AD, 38 bvFTD, and 17 DLB early-stage patients, along 63 cognitively healthy controls (HC), were prospectively recruited from Kuopio and Oulu University Hospitals. Non-motor symptoms were evaluated using the Non-Motor Symptoms Questionnaire (NMSQ), focusing on gastrointestinal, neuropsychiatric, cognitive, sleep-related and sensory-motor domains within three timeframes prior to the baseline visit. Results DLB patients exhibited the highest prevalence of non-motor symptoms across all domains. bvFTD and AD patients did not show disease group specific symptoms, but apathy and paranoidal thoughts appeared earlier in bvFTD than AD or DLB. Diplopia was reported by 14% of DLB patients (Fisher exact test, p = 0.035) one year before diagnosis. Neuropsychiatric and cognitive symptoms were more frequent in all dementia groups compared to HC (Fisher exact test, p < 0.01). Conclusions Non-motor symptom profiles differ among these dementia subtypes even at early stages, suggesting their potential utility as early disease-specific indicators.
Objective: Neuropsychiatric symptoms (NPS) are common across parkinsonian disorders. Symptom profiles vary by diagnosis and stage of disease, and individual symptoms may differentially affect everyday functioning. We evaluated the impact of NPS on functional status in Parkinson’s disease (PD), Lewy body disease (LBD)...
Andrea Collins, Jordan Kozuki, Lily Wilkin et al.· Archives of Clinical Neurops...· 0 citations
Background: Multiple sclerosis (MS) is characterized by heterogeneous trajectories of motor and cognitive disability. This study aimed to characterize longitudinal cognitive and motor trajectories across MS phenotypes and to identify baseline predictors of subsequent worsening. Methods: This retrospective cohort includ...
Giuseppe Romano, Maria Cropano, M. Fordellone et al.· Journal of Clinical Medicine· 0 citations
OBJECTIVE
To provide a reference for the clinical differentiation of behavioural variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD) by analysing differences in scores across various neuropsychiatric scales and their relationships with activities of daily living and caregiver burden.
STUDY DESIGN
A c...
Ling-Feng Zhang, Peng-Xing Lin, Yi-Pan Zhang et al.· Journal of the College of Ph...· 0 citations
Alzheimer’s disease (AD) co-pathology is common in dementia with Lewy bodies (DLB) and has been linked to poorer outcomes. However, its associations with domain-specific cognitive performance across the MCI/prodromal and dementia stages, and the relationship between cognitive performance and plasma biomarkers, re...
Elena Vera-Campuzano, Í. Rodríguez-Baz, Carla Abdelnour et al.· Alzheimer's Research & T...· 0 citations
Background: Parkinson’s disease impairs motor and nonmotor functions, potentially reducing health-related quality of life. Evidence regarding the associations of comorbid conditions, cognitive impairment, and disease duration with quality of life in regional healthcare settings remains limited.
Objective: To examine th...
Y. Astri, Maudita Nursanti· Glosains Jurnal Sains Global...· 0 citations
Background and Objectives Cognitive impairment affects 40%–70% of patients with multiple sclerosis (MS). Although recent hypothesis-driven and data-driven efforts have identified cognitive phenotypes, functional substrates underlying impairment in such phenotypes are still not clear. Our objective was to identify disti...
Kshiteeja Jain, P. Valsasina, Damiano Mistri et al.· Neurology(R) neuroimmunology...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.